Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Fennec Pharmaceuticals Q2 EPS $(0.21) Misses $(0.16) Estimate, Sales $3.33M Miss $3.73M Estimate

Author: Benzinga Newsdesk | August 03, 2023 06:25am
Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.16) by 31.25 percent. This is a 10.53 percent decrease over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $3.33 million which missed the analyst consensus estimate of $3.73 million by 10.86 percent.

Posted In: FENC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist